2. Anti-infection
  3. HIV Bacterial
  4. Ilimaquinone

Ilimaquinone, a marine sponge metabolite, displays anticancer activity via GADD153-mediated pathway. Ilimaquinone can induce vesiculation of the Golgi apparatus. Ilimaquinone exerts anti-HIV, anti-microbial, anti-inflammatory, and effects.

For research use only. We do not sell to patients.

Ilimaquinone Chemical Structure

Ilimaquinone Chemical Structure

CAS No. : 71678-03-0

Size Price Stock Quantity
100 μg USD 470 In-stock

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Ilimaquinone Related Antibodies

Top Publications Citing Use of Products

View All HIV Isoform Specific Products:

View All Isoforms
HIV HIV-1 HIV-2

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Ilimaquinone, a marine sponge metabolite, displays anticancer activity via GADD153-mediated pathway. Ilimaquinone can induce vesiculation of the Golgi apparatus[1]. Ilimaquinone exerts anti-HIV, anti-microbial, anti-inflammatory, and effects[2].

Cellular Effect
Cell Line Type Value Description References
A549 IC50
0.4 μg/mL
Compound: 4
Cytotoxicity against human A549 cells after 6 days by MTT assay
Cytotoxicity against human A549 cells after 6 days by MTT assay
[PMID: 9051909]
A549 IC50
5.9 μM
Compound: 14
Cytotoxicity against human A549 cells assessed as decrease in cell viability after 72 hrs by WST8 assay
Cytotoxicity against human A549 cells assessed as decrease in cell viability after 72 hrs by WST8 assay
[PMID: 28558970]
BV-2 IC50
10.4 μM
Compound: 7
Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-stimulated nitric oxide production by Griess assay
Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-stimulated nitric oxide production by Griess assay
[PMID: 28262525]
CHO-K1 GI50
2 μM
Compound: 1
Cytotoxicity against human CHOK1 cells after 48 hrs by SRB assay
Cytotoxicity against human CHOK1 cells after 48 hrs by SRB assay
[PMID: 21155589]
HeLa IC50
> 10 μM
Compound: 1
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 72 hrs by sulforhodamine B assay
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability after 72 hrs by sulforhodamine B assay
[PMID: 32040314]
HeLa IC50
7.6 μM
Compound: 14
Cytotoxicity against human HeLa cells assessed as decrease in cell viability after 72 hrs by WST8 assay
Cytotoxicity against human HeLa cells assessed as decrease in cell viability after 72 hrs by WST8 assay
[PMID: 28558970]
HT-29 GI50
5.4 μM
Compound: 1
Cytotoxicity against human HT-29 cells after 48 hrs by SRB assay
Cytotoxicity against human HT-29 cells after 48 hrs by SRB assay
[PMID: 21155589]
MCF7 IC50
> 10 μM
Compound: 1
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by sulforhodamine B assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by sulforhodamine B assay
[PMID: 32040314]
MCF7 GI50
3.9 μM
Compound: 1
Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay
Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay
[PMID: 21155589]
MCF7 IC50
8.3 μM
Compound: 14
Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 72 hrs by WST8 assay
Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 72 hrs by WST8 assay
[PMID: 28558970]
NCI-H460 GI50
1.8 μM
Compound: 1
Cytotoxicity against human H460 cells after 48 hrs by SRB assay
Cytotoxicity against human H460 cells after 48 hrs by SRB assay
[PMID: 21155589]
P388 IC50
0.2 μg/mL
Compound: 4
Cytotoxicity against mouse P388 cells after 3 days by MTT assay
Cytotoxicity against mouse P388 cells after 3 days by MTT assay
[PMID: 9051909]
PC-3 IC50
> 10 μM
Compound: 1
Antiproliferative activity against human PC3 cells assessed as reduction in cell viability by MTT assay
Antiproliferative activity against human PC3 cells assessed as reduction in cell viability by MTT assay
[PMID: 32040314]
SF-268 GI50
2.7 μM
Compound: 1
Cytotoxicity against human SF268 cells after 48 hrs by SRB assay
Cytotoxicity against human SF268 cells after 48 hrs by SRB assay
[PMID: 21155589]
WI-38 IC50
9.7 μM
Compound: 14
Cytotoxicity against human WI38 cells assessed as decrease in cell viability after 72 hrs by WST8 assay
Cytotoxicity against human WI38 cells assessed as decrease in cell viability after 72 hrs by WST8 assay
[PMID: 28558970]
In Vitro

Ilimaquinone induces a concentration-dependent anti-proliferative effect in several types of cancer cell lines, including prostate cancer PC-3 and LNCaP, non-small cell lung cancer A549 and hepatocellular carcinoma Hep3B cells. Ilimaquinone (0.3-30 μM ; 48 hours) inhibits the proliferation of PC-3 cells, DU145, LNCaP, MG63, A549, Hep3B cells with GI50s of 2.6 μM, 5.8, 4.6, 4.9, 4.1, 12.0μM, respectively[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Ilimaquinone Related Antibodies

Cell Viability Assay[1]

Cell Line: Prostate cancer PC-3 cells
Concentration: 0.3, 1, 3, 10, and 30 μM
Incubation Time: 48 hours
Result: Inhibited the proliferation of PC-3 cells in a concentration-dependent manner.
In Vivo

Ilimaquinone exhibits terminal elimination half-lives (T1/2=1.2±0.3 h) due to high plasma clearance (2.95±0.53 L/h/kg) following oral administration (10 mg/kg) in male Sprague-Dawley rats[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Molecular Weight

358.47

Formula

C22H30O4
CAS No.
Appearance

Solid

Color

Light yellow to brown

SMILES

C=C1[C@]2(CC[C@@H]([C@](C)([C@@]2(CCC1)[H])CC3=C(C(C=C(C3=O)OC)=O)O)C)C
Structure Classification
Initial Source

marine sponge Halichondria sp.
Shipping

Room temperature in continental US; may vary elsewhere.
Storage
Powder -20°C 3 years
In solvent -80°C 6 months
-20°C 1 month
Solvent & Solubility
In Vitro: 

DMSO : 25 mg/mL (69.74 mM; Need ultrasonic and warming; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.7896 mL 13.9482 mL 27.8963 mL
5 mM 0.5579 mL 2.7896 mL 5.5793 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
Purity & Documentation

Purity: ≥99.0%

SDS (251 KB)

COA (253 KB)

Handling Instructions (2659 KB)
References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 2.7896 mL 13.9482 mL 27.8963 mL 69.7408 mL
5 mM 0.5579 mL 2.7896 mL 5.5793 mL 13.9482 mL
10 mM 0.2790 mL 1.3948 mL 2.7896 mL 6.9741 mL
15 mM 0.1860 mL 0.9299 mL 1.8598 mL 4.6494 mL
20 mM 0.1395 mL 0.6974 mL 1.3948 mL 3.4870 mL
25 mM 0.1116 mL 0.5579 mL 1.1159 mL 2.7896 mL
30 mM 0.0930 mL 0.4649 mL 0.9299 mL 2.3247 mL
40 mM 0.0697 mL 0.3487 mL 0.6974 mL 1.7435 mL
50 mM 0.0558 mL 0.2790 mL 0.5579 mL 1.3948 mL
60 mM 0.0465 mL 0.2325 mL 0.4649 mL 1.1623 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Ilimaquinone Related Classifications

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Ilimaquinone71678-03-0HIVBacterialHuman immunodeficiency virusmarinespongemetaboliteanticancerGADD153Golgiapparatusanti-HIVanti-microbialanti-inflammatoryInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Ilimaquinone
Cat. No.:
HY-119500
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

English - EN (251 KB) Français - FR (251 KB) Deutsch - DE (251 KB) Norwegian - NO (251 KB) Español - ES (251 KB) Swedish - SV (251 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.